Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Researcher tests first-in-class compound for neuroprotection with hope of stopping MS disease progression

PUBLIC RELEASE DATE: 20-Nov-2013
 
Contact: Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine 
 
Researcher tests first-in-class compound for neuroprotection with hope of stopping MS disease progression
 
Mount Sinai's Patrizia Casaccia, M.D., partners with Karyopharm Therapeutics to speed new drug development
 
A $500,000 drug development grant from the National Multiple Sclerosis Society (NMSS) was awarded to a partnership be

ONLINE STUDY LOOKING AT EMOTION REGULATION IN MULTIPLE SCLEROSIS

 
The Clinical Neuroscience Laboratory at Ohio State University is looking for individuals with multiple sclerosis to participate in an online study examining relations between emotion regulation and quality of life in individuals with MS. The online study involves filling out a set of questionnaires and making subjective ratings about emotion-eliciting photos.

Pages

Subscribe to Multiple Sclerosis Discovery Forum RSS